Abstract

Human adipose tissue (hAT) is constituted of structural units termed lobules, the organization of which remains to be defined. Here we report that lobules are composed of two extracellular matrix compartments, i.e., septa and stroma, delineating niches of CD45−/CD34+/CD31− progenitor subsets characterized by MSCA1 (ALPL) and CD271 (NGFR) expression. MSCA1+ adipogenic subset is enriched in stroma while septa contains mainly MSCA1−/CD271− and MSCA1−/CD271high progenitors. CD271 marks myofibroblast precursors and NGF ligand activation is a molecular relay of TGFβ-induced myofibroblast conversion. In human subcutaneous (SC) and visceral (VS) AT, the progenitor subset repartition is different, modulated by obesity and in favor of adipocyte and myofibroblast fate, respectively. Lobules exhibit depot-specific architecture with marked fibrous septa containing mesothelial-like progenitor cells in VSAT. Thus, the human AT lobule organization in specific progenitor subset domains defines the fat depot intrinsic capacity to remodel and may contribute to obesity-associated cardiometabolic risks.

In human adipose tissue (AT), adipocytes are organized into units of lobules. Here the authors identify distinct fibrous septal and stromal compartments within AT lobules that differ in composition and potential between subcutaneous and visceral regions and are disturbed in obesity and metabolic syndrome.

Details

Title
Lobular architecture of human adipose tissue defines the niche and fate of progenitor cells
Author
Estève, D 1 ; Boulet, N 1   VIAFID ORCID Logo  ; Belles, C 1 ; Zakaroff-Girard, A 2 ; Decaunes, P 1 ; Briot, A 1   VIAFID ORCID Logo  ; Veeranagouda, Y 3   VIAFID ORCID Logo  ; Didier, M 3   VIAFID ORCID Logo  ; Remaury, A 3 ; Guillemot, J C 3 ; Ledoux, S 4 ; Dani, C 5 ; Bouloumié, A 1 ; Galitzky, J 1   VIAFID ORCID Logo 

 Université de Toulouse, BP84225, Inserm, UMR 1048, Team 1, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse Cedex 4, France (GRID:grid.11417.32) (ISNI:0000 0001 2353 1689) 
 Université de Toulouse, BP84225, Inserm, UMR 1048, Team 1, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse Cedex 4, France (GRID:grid.11417.32) (ISNI:0000 0001 2353 1689); Institute of Metabolic and Cardiovascular Diseases, BP84225, Inserm, UMR 1048, Cytometry Platform, I2MC, Toulouse Cedex 4, France (GRID:grid.11417.32) 
 Translational Sciences, Sanofi Aventis Research & Development, Chilly-Mazarin Cedex, France (GRID:grid.11417.32) 
 Université Paris Diderot, Center Support of Obesity, Louis Mourier Hospital, Colombes, France (GRID:grid.7452.4) (ISNI:0000 0001 2217 0017) 
 Université Côte-d’Azur, Inserm, CNRS iBV, Nice, France (GRID:grid.460782.f) (ISNI:0000 0004 4910 6551) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2238566993
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.